- Home
- CULP vs VTVT Comparison
CULP vs VTVT Comparison
Compare CULP & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CULP
- VTVT
- Stock Information
- Founded
- CULP 1972
- VTVT 2015
- Country
- CULP United States
- VTVT United States
- Employees
- CULP N/A
- VTVT N/A
- Industry
- CULP Textiles
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- CULP Consumer Discretionary
- VTVT Health Care
- Exchange
- CULP Nasdaq
- VTVT Nasdaq
- Market Cap
- CULP 54.5M
- VTVT 47.9M
- IPO Year
- CULP N/A
- VTVT 2015
- Fundamental
- Price
- CULP $4.79
- VTVT $19.76
- Analyst Decision
- CULP
- VTVT Strong Buy
- Analyst Count
- CULP 0
- VTVT 2
- Target Price
- CULP N/A
- VTVT $35.50
- AVG Volume (30 Days)
- CULP 19.0K
- VTVT 3.0K
- Earning Date
- CULP 09-10-2025
- VTVT 11-11-2025
- Dividend Yield
- CULP N/A
- VTVT N/A
- EPS Growth
- CULP N/A
- VTVT N/A
- EPS
- CULP N/A
- VTVT N/A
- Revenue
- CULP $207,391,000.00
- VTVT $17,000.00
- Revenue This Year
- CULP $2.41
- VTVT N/A
- Revenue Next Year
- CULP $3.46
- VTVT N/A
- P/E Ratio
- CULP N/A
- VTVT N/A
- Revenue Growth
- CULP N/A
- VTVT N/A
- 52 Week Low
- CULP $3.42
- VTVT $12.62
- 52 Week High
- CULP $6.85
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- CULP 67.63
- VTVT 71.89
- Support Level
- CULP $4.26
- VTVT $15.79
- Resistance Level
- CULP $4.80
- VTVT $21.01
- Average True Range (ATR)
- CULP 0.18
- VTVT 0.96
- MACD
- CULP 0.06
- VTVT 0.32
- Stochastic Oscillator
- CULP 98.61
- VTVT 76.02
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.